Table 3.
ICOC elasticity for treatment cost estimates with 1–3 years lagged
| ICOC elasticity | |||||||
|---|---|---|---|---|---|---|---|
| OP costs | IP costs | Total costs |
|||||
| OLS model | lag 1 year |
-0.02 (0.004) |
* |
0.08 (0.03) |
** |
-0.01 (0.006) |
*† |
| lag 2 years |
0.01 (0.005) |
† |
0.23 (0.03) |
* |
0.04 (0.01) |
* | |
| lag 3 years |
0.03 (0.005) |
* |
0.22 (0.04) |
* |
0.06 (0.007) |
* | |
| 2SLS model | lag1 year |
1.07 (0.21) |
* |
-23.32 (2.83) |
* |
-1.93 (0.32) |
* |
|
Weak Instrument (Anderson-Rubin Wald test F) |
37.72 | * | 351.86 | * | 65.52 | * | |
| Wald test for endogeneity χ2(1) | 39.51 | * | 353.67 | * | 61.78 | * | |
| lag 2 years |
-0.34 (0.18) |
-12.07 (1.94) |
* |
-1.94 (0.34) |
* | ||
|
Weak Instrument (Anderson-Rubin Wald test F) |
3.85 | † | 83.24 | * | 58.98 | * | |
| Wald test for endogeneity χ2(1) | 4.09 | † | 86.45 | * | 61.43 | * | |
| lag 3 years |
-0.89 (0.22) |
* |
-0.20 (1.51) |
-0.91 (0.31) |
* | ||
|
Weak Instrument (Anderson-Rubin Wald test F) |
22.22 | * | 0.02 | 10.40 | * | ||
| Wald test for endogeneity χ2(1) | 23.59 | * | 0.08 | 11.78 | * | ||
Note: *: p-value < 0.01; †: p-value < 0.05